Health Sciences Acquisitions

General Information


We are a blank check company formed under the laws of the State of Delaware on December 6, 2018. We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. Although there is no restriction or limitation on what industry our target operates in, it is our intention to pursue prospective targets that are focused on healthcare innovation. We anticipate targeting companies domiciled in North America or Europe that are developing assets in the biopharma and medical technology sectors, which aligns with our management team’s experience in healthcare investing and drug development. 

Employees: 0
Founded: 2018
Contact Information
Address 412 West 15th Street, Floor 9, New York, NY 10011, US
Phone Number (646) 343-9280
Web Address
View Prospectus: Health Sciences Acquisitions
Financial Information
Market Cap $125.0mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol HSACU
Exchange NASDAQ
Shares (millions): 10.0
Price range $10.00 - $10.00
Est. $ Volume $100.0 mil
Manager / Joint Managers Chardan/ UBS Investment Bank
CO-Managers -
Expected To Trade: 5/10/2019
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change